This animated video visually explores the distinct mechanisms of action (MOAs) of anticholinergics and VMAT-2 inhibitors in managing tardive dyskinesia.
Supported by an independent educational grant from Jazz Pharmaceuticals, Inc.
This animated video visually explores the distinct mechanisms of action (MOAs) of anticholinergics and VMAT-2 inhibitors in managing tardive dyskinesia.
Read the Transcript
Q: Should TD symptoms develop, how can providers reassess their patient's treatment course?
Read the transcript:
Hi, I'm Amber Hoberg. I'm a psychiatric mental health nurse practitioner from San Antonio, Texas, and I at work at Morningstar Family Medicine.